Document Detail


Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy.
MedLine Citation:
PMID:  11995485     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND/AIMS: Intra-arterial hepatic chemotherapy based on floxuridine infusion is an effective treatment for hepatic metastases from colorectal cancer. The aim of the present study is the comparative analysis of surgical and percutaneous transaxillary approaches to implant a catheter into the hepatic artery for intra-arterial hepatic chemotherapy with floxuridine. METHODOLOGY: Fifty-six patients received an arterial device for intra-arterial hepatic chemotherapy. Twenty-eight patients (LPT group) underwent laparotomy to implant the catheter into the hepatic artery, the other 28 patients (PCT group) received a percutaneous catheter into the hepatic artery through a transaxillary percutaneous access. Safety and efficacy of surgical and percutaneous transaxillary approaches were comparatively analyzed in terms of number of intra-arterial hepatic chemotherapy cycles administered, device-related complications causing suppression of intra-arterial hepatic chemotherapy, and biological costs of the procedures. RESULTS: Mean postoperative hospitalization was 8.2 +/- 2.2 days in the LPT group and 1.8 +/- 0.7 days in the PCT group (P < 0.0001), while mean analgesic requirements were 9.7 +/- 3.2 doses in the LPT group and 2 +/- 0.9 doses in the PCT group (P < 0.0001). Mean number of intra-arterial hepatic chemotherapy cycles administered was 6.5 +/- 4.2 in the LPT group and 4.3 +/- 3.4 in the PCT group (P = 0.038). The overall incidence of device-related complications causing suppression of intra-arterial hepatic chemotherapy was 42.7% in the PCT group and 7.1% in the LPT group (P = 0.005). CONCLUSIONS: Surgical implantation is still recommended when laparotomy has to be performed for other contextual procedures, such as colorectal or hepatic resection, while percutaneous transaxillary catheter placement is indicated for palliative or neoadjuvant intra-arterial hepatic chemotherapy.
Authors:
Luca Aldrighetti; Marcella Arru; Enzo Angeli; Massimo Venturini; Marco Salvioni; Monica Ronzoni; Roberto Caterini; Gianfranco Ferla
Related Documents :
6477105 - Complicated access for regional infusion chemotherapy. a consequence of variant hepatic...
11769545 - Arteriosclerosis in the influx and intravisceral arteries of the liver, kidney and lung...
3069465 - Hepatic artery aneurysm: diagnosis by duplex-doppler ultrasound. case report.
19539285 - Management of ongoing arterial haemorrhage after damage control laparotomy: optimal tim...
9013905 - Impact of arterial surgery and balloon angioplasty on amputation: a population-based st...
7070105 - Technical notes on long-term vascular access for more than 12 months in conscious dogs.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Hepato-gastroenterology     Volume:  49     ISSN:  0172-6390     ISO Abbreviation:  Hepatogastroenterology     Publication Date:    2002 Mar-Apr
Date Detail:
Created Date:  2002-05-08     Completed Date:  2002-12-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8007849     Medline TA:  Hepatogastroenterology     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  513-7     Citation Subset:  IM    
Affiliation:
Department of Surgery, Scientific Institute H San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. aldrighetti.luca@hsr.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antimetabolites, Antineoplastic / administration & dosage*
Catheters, Indwelling
Colorectal Neoplasms / pathology
Female
Floxuridine / administration & dosage*
Hepatic Artery
Humans
Infusion Pumps, Implantable*
Infusions, Intra-Arterial*
Laparotomy
Liver Neoplasms / drug therapy*,  secondary
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Antimetabolites, Antineoplastic; 50-91-9/Floxuridine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy.
Next Document:  Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.